Turn Therapeutics (TTRX) Shares Outstanding (2024 - 2026)

Turn Therapeutics' Shares Outstanding (Entity) history runs 3 years deep, the most recent figure standing at $29.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 9.29% year-over-year to $29.8 million; the TTM figure through Mar 2026 stood at $29.8 million (up 9.29% YoY), while the FY2025 annual figure was $29.4 million, up 9.68% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $29.8 million, up from $29.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $29.8 million in Q1 2026, with the low at $26.7 million in Q3 2024.
• The 3-year median for Shares Outstanding (Entity) is $27.6 million (2025), against an average of $28.0 million.
• Peak annual rise in Shares Outstanding (Entity) reached 9.68% in 2025, while the deepest fall reached 4.99% in 2025.
• Turn Therapeutics' Shares Outstanding (Entity) stood at $26.8 million in 2024, then increased by 9.68% to $29.4 million in 2025, then increased by 1.16% to $29.8 million in 2026.
• Business Quant data shows TTRX's Shares Outstanding (Entity) at $29.8 million in Q1 2026, $29.4 million in Q4 2025, and $28.0 million in Q3 2025.